Icon

SELZENTRY (nda022128)- (25MG,75MG,150MG,300MG)

MARAVIROC VIIV HLTHCARE
25MG,75MG,150MG,300MG
Yes No
2023-May-25 Expired
None None
None No
SELZENTRY is a CCR5 co-receptor antagonist indicated in combination with other antiretroviral agents for the treatment of only CCR5-tropic HIV-1 infection in adults and pediatric patients weighing at least 2 kg.
2 1 2
Total Other Developers 5
Drugs with Suitability No
25MG ** ** - - -
75MG ** ** - - -
150MG ** ** Up - 2
300MG ** ** Up - 2
NDA Sales Available Total Generic Sales Available
Yes 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** **** *** *** ****** **** ******* *********** **** ***, **** **. **-***, ****-**, ***, **********, *********, ********* ******, ***** (***) ***
****** ****** **** *** *** ****** *************** *** *********** *** ******** **, *********, *** **** (**) *****, ****** ****** (***) ***
****** * * ****** * * ***************, *** *********** *** **** ******, **********, ************ (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.